The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants

Marie-Noëlle Méaux, Anne-Laure Sellier-Leclerc, Cécile Acquaviva-Bourdain, Jérôme Harambat, Lise Allard, Justine Bacchetta

Open source

DOI
10.1007/s00467-021-05393-1
Published
2022-01-11
Container
Pediatric Nephrology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00467-021-05393-1,
  title = {The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants},
  author = {Marie-Noëlle Méaux and Anne-Laure Sellier-Leclerc and Cécile Acquaviva-Bourdain and Jérôme Harambat and Lise Allard and Justine Bacchetta},
  year = {2022},
  journal = {Pediatric Nephrology},
  doi = {10.1007/s00467-021-05393-1},
  url = {https://doi.org/10.1007/s00467-021-05393-1}
}

RIS

TY  - JOUR
TI  - The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants
AU  - Marie-Noëlle Méaux
AU  - Anne-Laure Sellier-Leclerc
AU  - Cécile Acquaviva-Bourdain
AU  - Jérôme Harambat
AU  - Lise Allard
AU  - Justine Bacchetta
PY  - 2022
JO  - Pediatric Nephrology
DO  - 10.1007/s00467-021-05393-1
UR  - https://doi.org/10.1007/s00467-021-05393-1
ER  - 

APA

Méaux, M., Sellier-Leclerc, A., Acquaviva-Bourdain, C., Harambat, J., Allard, L., & Bacchetta, J. (2022). The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants. Pediatric Nephrology. https://doi.org/10.1007/s00467-021-05393-1

Source records